Body composition and ankle-brachial index in Ghanaians with asymptomatic peripheral arterial disease in a tertiary hospital
© Yeboah et al. 2016
Received: 23 January 2016
Accepted: 9 May 2016
Published: 13 May 2016
Ankle-brachial index (ABI) and indices of obesity are both use to indicate cardiovascular risk. However, association between body composition indices and ABI, a measure of peripheral arterial disease, is inconsistent in various study reports. In this study, we investigated the relationship between ABI and general and central indices of obesity in Ghanaians without history of cardiovascular diseases.
In a case–control design, ABI was measured in a total of 623 subjects and categorised into PAD (ABI ≤ 0.9, n = 261) and non-PAD (ABI > 0.9, n = 362) groups. Anthropometric indices, BMI, waist circumference (WC), waist-hip ratio (WHR) and waist-height ratio (WHtR) were also measured.
PAD subjects had higher mean BMI (29.8 ± 8.7 vs. 26.5 ± 7.6 kg/m2, p = 0.043) and waist circumference (95 ± 15 vs. 92 ± 24 cm, p = 0.034) than non-PAD subjects. In multivariable logistic regression models, having BMI ≥ 30 kg/m2 increased the odds of both unilateral [OR (95 % CI): 2 (1.14–3.51), p < 0.01] and overall PAD [2 (1.22–3.27), p < 0.01].
In indigenous Ghanaians in our study, PAD participants had higher BMI and waist circumference than non-PAD participants. Also, halving BMI ≥ 30 kg/m2 was associated with twofold increase in the odds of PAD.
KeywordsObesity Ankle brachial index Peripheral arterial disease Diabetes Ghana
Peripheral arterial disease (PAD) is one of the debilitating cardiovascular diseases (CVDs) among diabetes patients and the older general population . Most PAD cases remain undetected until later stages of the disease when clinical symptoms become apparent . Ankle-brachial index (ABI), the ratio of systolic blood pressures of the arteries of the ankle to the arteries of the upper arm, is a simple, objective and non-invasive method of screening for PAD . The major risk factors for PAD are diabetes and smoking , however, the prevalence of smoking in Ghana is relatively low . The prevalence of symptomatic and asymptomatic PAD in diabetes patients far outweighs that of non-diabetic individuals . Obesity, characterized by excess body fat, is recognized as important factor for development of CVDs  including PAD . Obesity is assessed as body mass index (BMI) for generalized adiposity, and waist circumference (WC), waist-hip ratio (WHR) and waist-height ratio (WHtR) for central adiposity . Body composition and adiposity exhibit ethnic diversity, with indigenous Africans having different morphology compared to Caucasians . Also, there is no agreement on the best index of adiposity associated with CVDs. For instance, as some studies reported that, compared to BMI, indices of central obesity such as WC, WHR and WHtR are better determinant of CVD morbidity and mortality [10, 11]; other investigators found no superiority of these measures of abdominal obesity to BMI in CVD risk prediction . In this study, we investigated the association between various indices of obesity and PAD in subjects without any history of CVD. We hypothesize that obesity increases the odds of PAD in our study population.
This study was case control design, conducted within the period of August, 2009 to June, 2010, at the Korle-Bu Teaching Hospital in Accra, which is a 1500-bed tertiary hospital and serves as the main referral hospital in Ghana. ABI was measured in all the study population, which were selected from two sources: (1) diabetes patients, selected systematically as every 3rd consecutive patient visiting the diabetes clinic and consented to take part in the study, and (2) non-diabetic individuals, invited from the surrounding communities and conveniently recruited into the study. All the study participants were categorised as PAD and non-PAD based on the ABI values. Individuals with stiff incompressible arteries (ABI > 1.3), symptoms of classical intermittent claudication, history/medication of CVDs and those unable to comprehend and comply with the protocol requirements (psychological and/or cognitive disorders, failure to cooperate, failure to sign the informed consent document) were excluded from the study. The sample size was estimated to detect correlation coefficient of 0.2 and 0.3 between BMI and ABI in PAD and non-PAD subjects respectively; minimum of 186 subjects were required to power the study at 80 % with type I error rate of 5 %. In all, 261 PAD patients and 362 non-PAD subjects satisfied the inclusion criteria and were recruited into the study. The study was approved by the University of Ghana Medical School Ethical and Protocol Review Committee (Protocol ID number: MS-Et/M.2 – P.2.10/2009-2010) and all participants gave written informed consent after the procedures involved in the study were thoroughly explained to them, following the general recommendations of the Declaration of Helsinki.
Weight, height, waist and hip circumferences were measured using standard protocol . Briefly, body weight was determined on twice using a homologated electronic scale (Seca 770) following due calibration (precision ± 0.1 kg), with the patient wearing light clothing with shoes removed. Height was also measured with a portable system (Seca 222) with the patient shoeless in the upright position. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m2). BMI < 18.5 Kg/m2 were considered underweight, those within the range of 25–29.9 Kg/m2 were considered overweight and BMI ≥ 30 Kg/m2 were considered obese. Waist circumference was measured with non-elastic tape measure at the upper border of the iliac crest, parallel to the floor without compressing the skin. The reading was taken at the end of a normal breath, and WHR < 0.9 & WC < 102 cm for males and WHR <0.85 & WC < 88 cm for females were considered normal. WHtR was calculated as height divided by WC, with WHtR <0.5 considered normal .
Blood pressure was measured three times, with a validated Blood Pressure Monitor (Omron 991X, Omron Health Care, Japan), at the right upper arm of participants with an appropriate cuff size, after at least 5 min rest, seated comfortably with arm and back support. Hypertension was defined as subjects with BP ≥ 140/90 mmHg and/or on antihypertensive medication.
Ankle and brachial blood pressures were measured in all participants after a minimum of 5 min rest in a supine position on an examination table in a temperature controlled room. Blood pressure cuffs were applied to bare ankles with the midpoint of the bladder over the ankle arteries (dorsalis pedis and posterior tibial arteries) approximately 2 cm above the medial malleolus. Systolic blood pressure in both arms and ankles were obtained using an 8-MHz handheld Doppler (LifeDop® 250, Summit Doppler). For each limb, the cuff was inflated rapidly to the maximal inflation level and deflated at a rate of 2 mmHg per second until the systolic blood pressure became audible. Measurements were obtained in the following order: right arm, right ankle, left ankle, and left arm. ABI was calculated for each leg as the ratio of the higher of the systolic blood pressure in the ankle (dorsalis pedis and posterior tibia arteries) divided by the higher of systolic blood pressure in the arm. ABI >0.9 was considered normal and PAD was defined as ABI ≤ 0.9 in at least one leg . Since none of the participants had history/medication of CVDs, the level of atherosclerotic burden in PAD participants was estimated as unilateral (ABI ≤ 0.9 in one leg) or bilateral (ABI ≤ 0.9 in both legs) [13, 14]. Bilateral PAD has been reported to indicate more diffuse vaso-occlusion, as well as reduced arterial compliance, compared to unilateral PAD .
The data was analysed using IBM SPSS Version 20. Socio-demographic and clinical characteristics of study participants were analysed with student’s t-test for continuous variables and χ 2 test for categorical variables. Association between anthropometric indices and leg-specific ABI were assessed using multivariable regression with covariates forced into the model. The relationship between obesity and PAD status was analysed using logistic regression model with adjustment of covariates. p < 0.05 was considered statistically significant.
Socio-demographic and clinical characteristics by PAD status
All participants (n = 623)
PAD (n = 261)
Non-PAD (n = 362)
54.1 ± 10.6
54.2 ± 10.7
53.5 ± 10.2
Female, n (%)
Diabetes, n (%)
Duration of diabetes, yrs
6.8 ± 5.9
7.4 ± 6.2
6.2 ± 5.2
Hypertension, n (%)
28 ± 8.2
29.8 ± 8.7
26.5 ± 7.6
163 ± 11
163 ± 12
164 ± 12
Waist circumference, cm
93 ± 13
95 ± 15
92 ± 24
Hip circumference, cm
102 ± 12
103 ± 14
101 ± 10
0.92 ± 0.09
0.92 ± 0.09
0.92 ± 0.23
0.56 ± 0.07
0.59 ± 0.09
0.54 ± 0.07
Systolic BP, mmHg
133 ± 27
135 ± 25
130 ± 26
Diastolic BP, mmHg
80 ± 13
83 ± 13
79 ± 13
Pulse BP, mmHg
55 ± 19
56 ± 21
54 ± 15
Mean BP, mmHg
98 ± 15
98 ± 16
98 ± 15
Heart rate, bpm
70 ± 13
79 ± 16
63 ± 15
Employed, n (%)
Smoking, n (%)
Alcohol intake, n (%)
Insulin use, n (%)
Multivariable linear regression analysis of Anthropometric Indices and ABI
Multivariable logistic regression of obesity and PAD status
PAD (at least one leg)
β (95 % CI)
β (95 % CI)
β (95 % CI)
Employment (Ref: Full–time)
BMI groups (Ref: Normal)
WC (Ref: Normal)
WHR (Ref: Normal)
WHtR (Ref: Normal)
The main objective of this study was to investigate the association between indices of obesity and ABI-diagnosed PAD. Due to high burden of PAD in diabetes patients , we included substantial number of diabetes patients in order to obtain significant cases of PAD to compare with non-PAD controls. The findings of this study showed that, compared to non-PAD subjects, mean BMI and Waist circumference were higher in PAD subjects. Halving a higher BMI (≥30 kg/m2) doubled the likelihood of PAD after adjustment of some risk factors.
The relationship between BMI, an index of generalized adiposity, and PAD reported in various studies is inconsistent. Similar to our findings, other studies reported association between PAD (low ABI) and BMI. In Cardiovascular Health Study, Ix et al. reported that significant association between BMI and ABI exist only in non-smokers with good health status . Also, the Hearts of Brazil studies reported significant association between ABI-diagnosed PAD versus BMI, waist circumference and waist-hip ratio . However, in contrast to our findings, BMI ≥ 30 kg/m2 was reported to be protective against PAD in Spanish population . Others studies found no association between ABI and BMI [19, 20]. This lack of association between BMI and PAD may be explained by the masking effect of the U-shaped relationship between ABI and cardiovascular risk factors; individuals with ABI < 0.9 and ABI > 1.3 have similar high CVD risk. Therefore, in the design of this study, exclusion of subjects with ABI > 1.3 may partially explain the significant association between ABI and anthropometric indices.
Variation exist in blacks and Caucasian populations with respect to the burden of obesity and PAD. Comparative analysis of black participants in the Jackson Heart Study and Caucasians in Framingham Heart Study showed that African-Americans have higher burden of obesity and CVD risk factors, yet, the influence of obesity to CVD burden is lesser than that of Caucasians . Generally, blacks have high level of adiposity independent of diabetes and hypertension, which may also be associated with higher odds of PAD . Moreover, ethnic comparison of ABI in African-Americans and non-Hispanic whites reported in both the GENOA  and MESA  studies showed that African-Americans had lower mean ABI in both studies, but similar prevalence of PAD after adjustment of confounders.
Indices of abdominal adiposity, waist circumference and WHR, have been reported to be associated with PAD in both prospective [11, 25] and cross-sectional studies [10, 26]. BMI, waist circumference, WHR and WHtR are indices use to estimate amount and distribution of body fat, which is linked to the pathophysiology of vascular dysfunction . In obese subjects, adipose tissue is known to release several metabolites, cytokines and hormones that modulates liver-derived lipoproteins, clotting factors and inflammatory factors, which affect the atherogenic environment of the vessel wall, favouring the development of atherosclerotic vascular diseases such as PAD . Adipose tissue–derived factors also influence gene expression and function of cells involved in vascular homeostasis, such as endothelial cells, arterial smooth muscle cells, and monocytes/macrophages .
The findings of our study show that means of WHR were similar between PAD and non-PAD subjects, and in contrast to other studies . Also, higher waist circumference and WHR, biomarkers of central obesity, were not associated with PAD. Compared to Caucasians, body composition of black ethnicity is associated differently with CVD risk profile. With similar BMI and waist circumference, computed tomographic analysis showed that African-Americans had lower visceral fat than Hispanics and Caucasians . WHR and waist circumference are indices of fat accumulation in the abdominal viscera and intra-abdominal organs, with or without reference to fat accumulation in gluteo-femoral region respectively. As a marker of visceral fat accumulation, WHR and waist circumference reflect the relative inability of subcutaneous adipose tissue to act as a protective metabolic sink for the clearance and storage of extra energy derived from dietary triglycerides, leading to ectopic fat deposition in visceral adipose depots . Visceral adipose tissue and its adipose-tissue resident macrophages produce more pro-inflamatory cytokines like tumor necrosis factor-alpha and interleukin-6, and less athero-protective adiponectin, making visceral fat measurement a proxy for the level of atherogenicity . However, subcutaneous and visceral fat distribution exhibit ethnic variation, with Caucasians accumulating more fat in the abdominal region which can be readily mobilised, as blacks, on the contrary, accumulate fat in the subcutaneous region. In addition, visceral fat accumulation correlates with waist circumference better in Caucasians than Africans [9, 29]. This may partially explain the non-significant association between indices of central adiposity and risk of PAD prevalence in our study population.
The strength of this study is the relatively large sample size of equivalent proportion of PAD and non-PAD subjects, selected by systematic random sampling, and ABI measured in temperature controlled room. Also, subjects with stiff arteries, intermittent claudication and history of CVDs were excluded from the study. The major limitations include the study being a cross sectional clinic-based design, and hence, we cannot infer causality. Also, plasma biomarkers were not analysed to study the pathophysiological mechanisms relating obesity to PAD.
The findings of this study show that, in Ghanaian without any history of CVD, PAD patients had higher BMI and waist circumference than non-PAD subjects. In addition, halving a BMI ≥ 30 kg/m2 increased the odds of PAD by twofold.
Ethics, consent and permissions
The study was conducted in accordance with the Declaration of Helsinki and ethical approval was granted by the University of Ghana Medical School Ethical and Protocol Review Committee (Protocol ID number: MS-Et/M.3 – P.2.10/2009-2010). All participants gave written informed consent after thorough explanation of the procedures involved.
Availability of data and materials
The dataset supporting the conclusions of this article is readily available for systematic review & meta-analysis upon request.
body mass index
peripheral arterial disease
The authors thank the staff of National Diabetes Management & Research Centre and staff of Diabetes Research & Chronic Disease Reference Laboratory.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UK, Williams LJ, Mensah GA. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–40.View ArticlePubMedGoogle Scholar
- Novo S. Classification, epidemiology, risk factors, and natural history of peripheral arterial disease. Diabetes Obes Metab. 2002;4:S1–6.View ArticlePubMedGoogle Scholar
- Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, Fowkes FGR, Hiatt WR, Jönsson B, Lacroix P, et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation. 2012;126(24):2890–909.View ArticlePubMedGoogle Scholar
- Brathwaite R, Addo J, Smeeth L, Lock K. A systematic review of tobacco smoking prevalence and description of tobacco control strategies in Sub-Saharan African countries; 2007 to 2014. PLoS One. 2015;10(7):e0132401.View ArticlePubMedPubMed CentralGoogle Scholar
- Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, Burt V, Curtin L, Engelgau M, Geiss L. Prevalence of lower-extremity disease in the U.S. adult population ≥40 years of age with and without diabetes: 1999–2000 National Health and Nutrition Examination Survey. Diabetes Care. 2004;27(7):1591–7.View ArticlePubMedGoogle Scholar
- Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29(24):2959–71.View ArticlePubMedGoogle Scholar
- McDermott MM, Criqui MH, Ferrucci L, Guralnik JM, Tian L, Liu K, Greenland P, Tan J, Schneider JR, Clark E, et al. Obesity, weight change, and functional decline in peripheral arterial disease. J Vasc Surg. 2006;43(6):1198–204.View ArticlePubMedPubMed CentralGoogle Scholar
- World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation. In: The World Health Organization (WHO) Expert Consultation on Waist Circumference and Waist-Hip Ratio: 2011. Geneva: WHO; 2008.Google Scholar
- Carroll JF, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, Vishwanatha JK, Bae S, Cardarelli R. Visceral Fat, waist circumference, and BMI: impact of race/ethnicity. Obesity. 2008;16(3):600–7.View ArticlePubMedGoogle Scholar
- Lu B, Zhou J, Waring ME, Parker DR, Eaton CB. Abdominal obesity and peripheral vascular disease in men and women: a comparison of waist-to-thigh ratio and waist circumference as measures of abdominal obesity. Atherosclerosis. 2010;208(1):253–7.View ArticlePubMedGoogle Scholar
- Cronin O, Morris DR, Walker PJ, Golledge J. The association of obesity with cardiovascular events in patients with peripheral artery disease. Atherosclerosis. 2013;228(2):316–23.View ArticlePubMedGoogle Scholar
- Planas A, Clara A, Contreras C, Gasol A, De Moner A, Vidal-Barraquer F, Marrugat J, Pou J. Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men. Atherosclerosis. 2000;151(1):274.View ArticleGoogle Scholar
- Brevetti G, Silvestro A, Di Giacomo S, Bucur R, Di Donato A, Schiano V, Scopacasa F. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg. 2003;38(2):374–9.View ArticlePubMedGoogle Scholar
- Wang JC, Criqui MH, Denenberg JO, McDermott MM, Golomb BA, Fronek A. Exertional leg pain in patients with and without peripheral arterial disease. Circulation. 2005;112(22):3501–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Mwebaze RM, Kibirige D, Okello S, Millard A, Owori R, Asiimwe SB, Siedner MJ, Rwebembera J, Wilson LA, Moore CC, et al. Peripheral arterial disease among adult diabetic patients attending a large outpatient diabetic clinic at a national referral hospital in Uganda: a descriptive cross sectional study. Prevalence of lower extremity peripheral artery disease among adult diabetes patients in southwestern Uganda. PLoS One. 2014;9(8):e105211. doi:10.1371/journal.pone.0105211. eCollection 0102014.View ArticlePubMedPubMed CentralGoogle Scholar
- Ix JH, Biggs ML, Kizer JR, Mukamal KJ, Djousse L, Zieman SJ, de Boer IH, Nelson TL, Newman AB, Criqui MH et al. Association of body mass index with peripheral arterial disease in older adults: the cardiovascular health study. Am J Epidemiol. 2011;174(9):1036–43. doi:10.1093/aje/kwr228. Epub 2011 Sep 13.View ArticlePubMedPubMed CentralGoogle Scholar
- Makdisse M, Pereira AC, Brasil DP, Borges JL, Machado-Coelho GLL, Krieger JE, Nascimento Neto RM, Chagas ACP. Prevalência e fatores de risco associados à doença arterial periférica no projeto corações do Brasil. Arq Bras Cardiol. 2008;91:402–14.View ArticleGoogle Scholar
- Alzamora MT, Forés R, Baena-Díez JM, Pera G, Toran P, Sorribes M, Vicheto M, Reina MD, Sancho A, Albaladejo C, et al. The Peripheral Arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population. BMC Public Health. 2010;10(1):1–11.View ArticleGoogle Scholar
- Oyelade BO, Olaolorun AD, Odeigah LO, Amole IO, Aderibigbe SA. The relationship between obesity and peripheral arterial disease in adult Nigerian diabetics. Niger Postgrad Med J. 2014;21(1):57–60.PubMedGoogle Scholar
- Planas A, Clara A, Pou JM, Vidal-Barraquer F, Gasol A, de Moner A, Contreras C, Marrugat J. Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men. Int J Obes Relat Metab Disord. 2001;25(7):1068–70.View ArticlePubMedGoogle Scholar
- Taylor HA, Coady SA, Levy D, Walker ER, Vasan RS, Liu J, Akylbekova EL, Garrison RJ, Fox C. Relationships of BMI to cardiovascular risk factors differ by ethnicity. Obesity. 2010;18(8):1638–45.View ArticlePubMedPubMed CentralGoogle Scholar
- Criqui MH, Vargas V, Denenberg JO, Ho E, Allison M, Langer RD, Gamst A, Bundens WP, Fronek A. Ethnicity and peripheral arterial disease: the San Diego population study. Circulation. 2005;112(17):2703–7.View ArticlePubMedGoogle Scholar
- Kullo IJ, Bailey KR, Kardia SL, Mosley TH, Boerwinkle E, Turner ST. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med. 2003;8(4):237–42.View ArticlePubMedGoogle Scholar
- Carnethon MR, Bertoni AG, Shea S, Greenland P, Ni H, Jacobs DR, Saad M, Liu K. Racial/ethnic differences in subclinical atherosclerosis among adults with diabetes: the multiethnic study of atherosclerosis. Diabetes Care. 2005;28(11):2768–70.View ArticlePubMedGoogle Scholar
- Giugliano G, Brevetti G, Laurenzano E, Brevetti L, Luciano R, Chiariello M. The prognostic impact of general and abdominal obesity in peripheral arterial disease. Int J Obes. 2009;34(2):280–6.View ArticleGoogle Scholar
- Makdisse M, Pereira Ada C, Brasil Dde P, Borges JL, Machado-Coelho GL, Krieger JE, Nascimento Neto RM, Chagas AC. Prevalence and risk factors associated with peripheral arterial disease in the Hearts of Brazil Project. Arq Bras Cardiol. 2008;91(6):370–82.View ArticlePubMedGoogle Scholar
- Chen L, Peeters A, Magliano DJ, Shaw JE, Welborn TA, Wolfe R, Zimmet PZ, Tonkin AM. Anthropometric measures and absolute cardiovascular risk estimates in the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. Eur J Cardiovasc Prev Rehabil. 2007;14(6):740–5.View ArticlePubMedGoogle Scholar
- Fantuzzi G, Mazzone T. Adipose tissue and atherosclerosis: exploring the connection. Arterioscler Thromb Vasc Biol. 2007;27(5):996–1003.View ArticlePubMedGoogle Scholar
- Després J-P, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49.View ArticlePubMedGoogle Scholar
- Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2(4):367–73.View ArticlePubMedGoogle Scholar